Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Brecht

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
International Journal of Clinical Pharmacology Research|December 4, 2004
Health-economic comparison of three recommended drugs for the treatment of osteoporosisJ G Brecht, H P Kruse, W Möhrke, et al.
International Journal of Clinical Pharmacology Research|July 1, 2004
Pharmacoeconomic analysis of osteoporosis treatment with risedronateJ G Brecht, H P Kruse, D Felsenberg, et al.
Pharmacoeconomics|July 24, 2001
Cost effectiveness of ramipril in patients with non-diabetic nephropathy and hypertension: economic evaluation of Ramipril Efficacy in Nephropathy (REIN) Study for Germany from the perspective of statutory health insuranceP K Schädlich, J G Brecht, M Brunetti, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 15, 1995
[Recommendations of the German Society of Clinical Pharmacology and Therapy for implementing and evaluating pharmaco-economic studies]J G Brecht, A Jenke, M E Köhler, et al.
Zeitschrift Fur Rheumatologie|March 3, 2004
[Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany]P K Schädlich, H Zeidler, A Zink, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
International Journal of Clinical Pharmacology Research|December 4, 2004
Health-economic comparison of three recommended drugs for the treatment of osteoporosisJ G Brecht, H P Kruse, W Möhrke, et al.
International Journal of Clinical Pharmacology Research|July 1, 2004
Pharmacoeconomic analysis of osteoporosis treatment with risedronateJ G Brecht, H P Kruse, D Felsenberg, et al.
Pharmacoeconomics|July 24, 2001
Cost effectiveness of ramipril in patients with non-diabetic nephropathy and hypertension: economic evaluation of Ramipril Efficacy in Nephropathy (REIN) Study for Germany from the perspective of statutory health insuranceP K Schädlich, J G Brecht, M Brunetti, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 15, 1995
[Recommendations of the German Society of Clinical Pharmacology and Therapy for implementing and evaluating pharmaco-economic studies]J G Brecht, A Jenke, M E Köhler, et al.
Zeitschrift Fur Rheumatologie|March 3, 2004
[Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany]P K Schädlich, H Zeidler, A Zink, et al.
Pageof 3